The 14th Canadian Symposium on Hepatitis C Virus: From research breakthroughs to equitable health care for priority populations
Elakpa Daniel Ngbede, David Lawton, Trinity H. Tooley, Kerryn van Rooyen et autres
Background: The hepatitis C virus (HCV) affects approximately 214,000 Canadians. While the availability of safe, effective direct-acting antivirals (DAA) has led to decreased rates of chronic HCV infection and increased treatment uptake, major challenges to achieving HCV elimination remain. This report summarizes …
ca, au (code pays fourni par la source)
0 citations
Canadian Liver Journal